P3 Health Partners Inc. (PIII)
NASDAQ: PIII · Real-Time Price · USD
10.22
-0.28 (-2.67%)
Jul 30, 2026, 4:00 PM EDT - Market closed
P3 Health Partners Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '20 Dec 31, 2020 |
| 1,472 | 1,459 | 1,500 | 1,266 | 1,049 | 485.54 | |
Revenue Growth | -0.87% | -2.76% | 18.48% | 20.67% | 116.15% | 232.80% |
Cost of Revenue | 1,504 | 1,538 | 1,613 | 1,222 | 1,046 | 464.97 |
Gross Profit | -31.97 | -78.91 | -112.62 | 44.34 | 3.71 | 20.57 |
Selling, General & Admin | 107.82 | 107.23 | 113.93 | 125.6 | 162.38 | 54.89 |
Depreciation & Amortization Expenses | 84.19 | 84.16 | 86.06 | 86.68 | 87.29 | 0.8 |
Other Operating Expenses | - | - | 8.06 | - | 1,315 | - |
Total Operating Expenses | 192 | 191.39 | 208.04 | 212.27 | 1,565 | 55.69 |
Operating Income | -223.98 | -270.3 | -320.66 | -167.93 | -1,561 | -35.12 |
Interest Expense | -63.08 | -55.03 | -22.17 | -15.99 | -11.4 | - |
Other Non-Operating Income (Expense) | 1.37 | 4.27 | 36.84 | 0.18 | 12.62 | -10.26 |
Total Non-Operating Income (Expense) | -61.87 | -50.76 | 14.67 | -15.8 | 1.22 | -10.26 |
Pretax Income | -285.85 | -321.06 | -305.99 | -183.73 | -1,560 | -45.38 |
Provision for Income Taxes | -10.05 | 2.03 | 4.39 | 2.7 | 1.86 | - |
Net Income | -275.8 | -323.09 | -310.38 | -186.43 | -1,562 | -45.38 |
Minority Interest in Earnings | -149.56 | -175.14 | -174.53 | -128.65 | -1,291 | -4.31 |
Net Income to Common | -126.25 | -147.95 | -135.85 | -57.77 | -270.13 | -41.07 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 3 | 3 | 3 | 1 | 1 | 0 |
Shares Outstanding (Diluted) | 3 | 3 | 3 | 1 | 1 | 0 |
Shares Change | 12.57% | 11.19% | 253.54% | - | 5128.95% | 99.20% |
EPS (Basic) | -38.55 | -45.26 | -46.78 | -30.50 | -325.00 | -2582.74 |
EPS (Diluted) | -38.60 | -45.26 | -54.06 | -31.50 | -325.00 | -2582.74 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -27.47 | -91.16 | -110.13 | -77.86 | -128.25 | -27.52 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -8.40 | -27.89 | -37.46 | -93.62 | -154.23 | -1730.60 |
Gross Margin | -2.17% | -5.41% | -7.51% | 3.50% | 0.35% | 4.24% |
Operating Margin | -15.21% | -18.53% | -21.37% | -13.26% | -148.73% | -7.23% |
Profit Margin | -18.73% | -22.14% | -20.69% | -14.72% | -148.80% | -9.35% |
FCF Margin | -1.87% | -6.25% | -7.34% | -6.15% | -12.22% | -5.67% |
EBITDA | -202.9 | -186.14 | -234.6 | -81.26 | -1,474 | -34.33 |
EBITDA Margin | -13.78% | -12.76% | -15.64% | -6.42% | -140.42% | -7.07% |
EBIT | -223.98 | -270.3 | -320.66 | -167.93 | -1,561 | -35.12 |
EBIT Margin | -15.21% | -18.53% | -21.37% | -13.26% | -148.73% | -7.23% |
Effective Tax Rate | 3.51% | -0.63% | -1.43% | -1.47% | -0.12% | 0.00% |